| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Timothy M Shannon last filed a Form 4 in June 2023, as Director at CTMX. The filings on record cover 5 companies. From October 2015 to September 2021, the filings on record show 8 open-market purchases and 19 sales. Timothy M Shannon's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Timothy M Shannon's trades have earned a strong insider score of 82/100 across 12 rated trades. Over a 12-month horizon, 91.7% of those trades were profitable, with an average 12-month return of +40.4%.
At the last filing, the largest reported position was 2,660,713 shares of IDYA. Net of sales, the IDYA filings show accumulation of 400,000 shares.
Shares as reported in the last Form 4 for each company; the most recent is from June 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2019 | ARVN Arvinas, Inc. | Director | Buy | 3,500 | $14.69 | $51,409.75 | +6.3% | |
| Oct 1, 2018 | ARVN Arvinas, Inc. | Director | Buy | 4,000 | $16.00 | $64,000.00 | +7.8% | |
| Nov 29, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 22,086 | $11.18 | $247,007.62 | -0.7% | |
| Nov 28, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 38,459 | $11.56 | $444,404.44 | -1.0% | |
| Nov 22, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 42,550 | $11.71 | $498,077.54 | -1.1% | |
| Nov 21, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 45,324 | $11.61 | $526,087.76 | -1.2% | |
| Nov 16, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 51,581 | $11.50 | $593,428.35 | -1.3% | |
| Nov 14, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 86,270 | $11.16 | $962,906.75 | -2.2% | |
| Nov 9, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 13,730 | $11.03 | $151,498.19 | -0.3% | |
| Jun 10, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 48,427 | $10.07 | $487,498.32 | -1.1% |